Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"BRAF protein, human"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Vanella%2C+Vito%22&type=Person&filter%5B%5D=topic_facet%3A%22BRAF+protein%2C+human%22
/vufind/Search/Results?lookfor=%22Vanella%2C+Vito%22&type=Person&filter%5B%5D=topic_facet%3A%22BRAF+protein%2C+human%22
Search /vufind/Search2/Results?lookfor=%22Vanella%2C+Vito%22&type=Person&filter%5B%5D=topic_facet%3A%22BRAF+protein%2C+human%22
PubPharm (9)
1
BRAF inhibitor cessation prior to disease progression in metastatic melanoma : Long-term outcomes
enthalten in:
European journal of cancer (Oxford, England : 1990)
| 2023
von
Lee, J.
|
Ahmed, T.
|
Maurichi, A.
| +19
Wird geladen...
2
Long-term outcomes and persistent toxicities following BRAF/MEK inhibitor therapy for advanced melanoma
enthalten in:
European journal of cancer (Oxford, England : 1990)
| 2023
von
Goodman, R.
|
Di Guardo, L.
|
Maurichi, A.
| +20
Wird geladen...
3
Identification of a miRNA-based non-invasive predictive biomarker of response to target therapy in BRAF-mutant melanoma
enthalten in:
Theranostics
| 2022
von
Ruggiero, C.
|
Fattore, L.
|
Terrenato, I.
| +19
Wird geladen...
4
The Role of BRAF-Targeted Therapy for Advanced Melanoma in the Immunotherapy Era
enthalten in:
Current oncology reports
| 2019
von
Vanella, V.
|
Festino, L.
|
Trojaniello, C.
| +4
Wird geladen...
5
Encorafenib in combination with binimetinib for unresectable or metastatic melanoma with BRAF mutations
enthalten in:
Expert review of clinical pharmacology
| 2019
von
Trojaniello, C.
|
Festino, L.
|
Vanella, V.
| +1
ErratumIn: Expert Rev Clin Pharmacol. 2021 Jan;14(1):i. - PMID 32501733
Wird geladen...
6
Combination Treatment of Patients with BRAF-Mutant Melanoma : A New Standard of Care
enthalten in:
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
| 2017
von
Simeone, E.
|
Grimaldi, A.
|
Festino, L.
| +3
Wird geladen...
7
Cessation of targeted therapy after a complete response in BRAF-mutant advanced melanoma : a case series
enthalten in:
British journal of cancer
| 2016
von
Carlino, M.
|
Vanella, V.
|
Girgis, C.
| +7
Wird geladen...
8
Complete response to nivolumab monotherapy in a treatment-naive, BRAF wild-type patient with advanced mucosal melanoma and elevated lactate dehydrogenase : a case report from a phase III trial
enthalten in:
Cancer immunology, immunotherapy : CII
| 2016
von
Ascierto, P.
|
Vanella, V.
|
Grimaldi, A.
| +4
Wird geladen...
9
Novel mechanisms and therapeutic approaches in melanoma : targeting the MAPK pathway
enthalten in:
Discovery medicine
| 2015
von
Grimaldi, A.
|
Simeone, E.
|
Festino, L.
| +3
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: BRAF protein, human
Medienart
9
Aufsätze
9
E-Artikel
9
E-Ressourcen
Zeitschriftentitel
2
European journal of cancer (Oxford, England : 1...
1
BioDrugs : clinical immunotherapeutics, biophar...
1
British journal of cancer
1
Cancer immunology, immunotherapy : CII
1
Current oncology reports
1
Discovery medicine
1
Expert review of clinical pharmacology
1
Theranostics
Alle anzeigen ...
weniger ...
Thema
BRAF protein, human
9
EC 2.7.11.1
9
Journal Article
9
Proto-Oncogene Proteins B-raf
5
Protein Kinase Inhibitors
4
Melanoma
4
Review
3
Antineoplastic Agents
3
Research Support, Non-U.S. Gov't
2
Binimetinib
2
EC 2.7.12.2
2
Mitogen-Activated Protein Kinase Kinases
2
Nivolumab
2
PD-1
2
PDCD1 protein, human
2
Programmed Cell Death 1 Receptor
2
Targeted therapy
1
181R97MR71
1
31YO63LBSN
1
8L7891MRB6
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
3
2020-
6
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
9
Englisch
Haven't found what you're looking for?
Wird geladen...